Transient Hyperlipidemia: Lipid Tests and Gene Causes
Short-lived rises in cholesterol and triglycerides still carry risk, so lipid panels come first. ZIP4, ZnT2 and Bartter's syndrome are among the causes discussed.
Brandon Colby, MD
MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
About Brandon
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
- BA in Genetics with Honors, University of Michigan · 2000
- MD, Mount Sinai School of Medicine · 2004
- MBA, Stanford University Graduate School of Business · 2007
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Unraveling the Mysteries of Trifascicular Block: The Role of Genetic Testing
Discover the role of genetic testing in diagnosing trifascicular block, a complex heart condition, and how it can guide personalized treatment and risk assessment.
Decoding Triosephosphate Isomerase Manchester: Understanding, Diagnosing, and Genetic Testing
Progressive neuromuscular degeneration and seizures follow reduced TPI activity in glycolysis. Enzyme assays, TPI gene testing and prenatal options are set out.
Unraveling the Mysteries of Triple-Negative Breast Cancer: Genetic Testing and Novel Treatment Approaches
About 15-20% of breast cancers are triple-negative. Biopsy receptor testing, ctDNA monitoring and AKT, checkpoint and PARP inhibitors are each explained here.
Unlocking the Mystery of Abacavir Hypersensitivity: The Power of Genetic Testing
Discover the power of genetic testing in diagnosing abacavir hypersensitivity, preventing adverse reactions, and personalizing HIV treatment for improved patient outcomes.
Understanding Abnormal Corpus Callosum Morphology
Discover the importance of diagnosing abnormal corpus callosum morphology, its connection to genetic syndromes, and how genetic testing can guide treatment decisions.
Inherited and Acquired Coagulation Abnormalities
PT, aPTT and thrombin time show how well clotting factors work, while genetic testing separates inherited coagulation problems from acquired ones.
Decoding the Enigma of Neuronal Migration Abnormalities
Neurons that never reach their place in the developing brain give rise to polymicrogyria and subcortical band heterotopia; MRI, exome sequencing and MLPA are used.